Parenteral to Enteral Feeding – Shift is Bolstering Growth of the Enteral Feeding Tubes Market
Shift from parenteral nutrition towards enteral feeding continues to remain a potential influencer for growth of the enteral feeding tubes market. Benefit of enteral feeding being improvement in intestinal blood flow stimulation along due to enhanced maintenance of the GI mucosal barrier has driven the adoption of enteral feeding worldwide. In addition, enteral feeding also enhances pancreatic functionalities alongside maintaining mass of small intestine, improving healing and recovery quotient, reducing risk of infection and lowering muscle catabolism. According to the analysis of German Medical Science Journal, septic complications impact around 3% individuals that are on enteral feeding, as compared to over 20% of those who are on parenteral nutrition. The transition to enteral from parenteral feeding has significantly bolstered the growth of the enteral feeding tubes market.
Oncology to Largely Contribute to the Enteral Feeding Tubes Market Growth
Demand for enteral feeding tubes from the oncology domain is poised to witness a significant spike in the years to follow. Increasing prevalence of cancer cases has spurred use of enteral feeding tubes to provide optimum nutrition to cancer affected patients. Individuals suffering from Head and Neck Squamous Cell Cancer (HNSCC) experience anorexia, weight loss, anaemia, and asthenia. In these cases, presence of tumors near oesophageal tissue and the corresponding damage from treatments result in poor weight management along with inadequate nutritional flow. This resulted in an increase in the use of enteral feeding tubes to supplement the patient with adequate nutrition. According to the World Health Organization (WHO), in 2020, cancer accounted for about 10 million deaths. Additionally, American Society of Clinical Oncology (ASCO) analysis reflected that over 66,600 individuals in the United States developed head and neck cancer.
Additionally, gastric cancer is the fifth common chronic disease and a third leading death cause worldwide. World Health Organization reveals that about 1.09 million individuals were diagnosed with stomach cancer on the global front. The anorexia-cachexia syndrome in stomach is caused mainly due to obstruction in the upper digestive tract, given the mechanical tumour effects. Hence, nutrition flow through enteral feeding has been an apt recommendation to patients suffering from this syndrome. In this background, increasing prevalence of cancer is expected to fuel the growth of the market.
Asia Pacific Likely to Showcase Higher Dependence on Enteral Feeding
Asia Pacific region is expected to showcase high growth potential with respect to adoption of enteral feeding tubes in the coming years. Emerging economies such as India and China, that are highly populated, are poised to have a significant share in the Asia Pacific enteral feeding tubes market. This can be attributed towards increasing incidences of preterm births coupled with growing aging population in these countries. According to World Health Organization (WHO), during 2015-2016, preterm births across China crossed 1.7 million, while preterm births in India alone touched a peak of more than 3 million in 2016. This statistics is expected to further increase in the following years, says WHO. Against this backdrop, it is imperative to enhance feeding of a premature baby in order to shun the mortality rate. UNICEF analysis shows that in 2018, around 2.5 million newborn mortalities were recorded in India off which major accountability was from preterm births. This aspect has pushed the need for enteral nutrition, in turn influencing growth of the market.
In addition, rising number of cancer incidences across India and China is another factor triggering demand for enteral nutrition. According to the Indian Council of Medical Research (IMCR), in 2018, more than 1.1 million cancer cases were observed in India, touching a count of over 1.7 million in 2020. This prompted enteral feeding to cancer patients that require high nutrition during the phase. This factor complements the growth of the regional market.
Enteral Feeding Tubes Market: Competitive Landscape
Key players in the market are focusing on growth strategies such as product expansion, partnerships, and collaborations to improve their market position. For instance, in 2021, Syncro Medical Innovations Inc., and Hatch Medical LLC partnered to commercialize GFTB (Gabriel Feeding Tube with Balloon). In 2020, Applied Medical Technology Inc. expanded its G-JET offering to include gastric-jejunal feeding tube in its G-JET portfolio.
Few of the major players operating in the enteral feeding tubes market include Cardinal Health, B Braun Melsungen AG, Boston Scientific Corporation, Applied Medical Technology Inc., and ENvizion Medical Inc.
Global Enteral Feeding Tubes Market is Segmented as Below:
By Disease Condition
By Tube Type
By Tube Placement
Key Elements Included In The Study: Global Enteral Feeding Tubes Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Under uncertainty, traditional approaches to strategic planning can be downright dangerous. True ambiguity is no basis to forecast the future – degree of risk, the magnitude of circumstances, conditions and consequences are not known or unpredictable. To avoid dangerous binary views of uncertainty; strategic posture, moves and actions through market research is the best bet.Read more